Prenetics Global (NASDAQ:PRE – Get Free Report) and Bio-Rad Laboratories (NYSE:BIO – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.
Insider and Institutional Ownership
25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by company insiders. Comparatively, 17.1% of Bio-Rad Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Risk and Volatility
Prenetics Global has a beta of -0.31, meaning that its stock price is 131% less volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Prenetics Global | -191.73% | -16.45% | -13.34% |
| Bio-Rad Laboratories | -30.18% | 3.74% | 2.65% |
Earnings and Valuation
This table compares Prenetics Global and Bio-Rad Laboratories”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Prenetics Global | $21.74 million | 3.13 | -$62.72 million | ($3.99) | -1.40 |
| Bio-Rad Laboratories | $2.67 billion | 3.27 | -$637.32 million | ($27.33) | -11.42 |
Prenetics Global has higher earnings, but lower revenue than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings for Prenetics Global and Bio-Rad Laboratories, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Prenetics Global | 0 | 0 | 1 | 0 | 3.00 |
| Bio-Rad Laboratories | 0 | 2 | 3 | 0 | 2.60 |
Prenetics Global currently has a consensus price target of $9.00, indicating a potential upside of 61.29%. Bio-Rad Laboratories has a consensus price target of $395.20, indicating a potential upside of 26.62%. Given Prenetics Global’s stronger consensus rating and higher possible upside, analysts clearly believe Prenetics Global is more favorable than Bio-Rad Laboratories.
Summary
Bio-Rad Laboratories beats Prenetics Global on 9 of the 14 factors compared between the two stocks.
About Prenetics Global
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
